The largest RCT on this topic, the MIG trial, initially found a significantly higher rate of large for gestational age (LGA) births and preterm delivery in mothers treated with metformin (plus supplemental insulin if required) than in those treated with insulin for the management of GDM [109]. This evidence concerns the gene INS and gestational diabetes.